MR imaging findings of low-grade serous carcinoma of the ovary: comparison with serous borderline tumor
Sign Up to like & getrecommendations! Published in 2020 at "Japanese Journal of Radiology"
DOI: 10.1007/s11604-020-00960-2
Abstract: Purpose To assess MR imaging findings of low-grade serous carcinoma (LGSC) of the ovary compared with those of serous borderline tumor (SBT). Methods Twenty-four patients with histopathologically proven 7 LGSCs and 25 SBTs who underwent… read more here.
Keywords: grade serous; imaging findings; serous carcinoma; findings low ... See more keywords
Carcinosarcoma of the ovary: MR and clinical findings compared with high-grade serous carcinoma
Sign Up to like & getrecommendations! Published in 2020 at "Japanese Journal of Radiology"
DOI: 10.1007/s11604-020-01072-7
Abstract: To clarify imaging and clinical characteristics of ovarian carcinosarcoma (CS) compared with high-grade serous carcinoma (HGSC). We retrospectively reviewed MR imagings of 12 patients with CS and 30 patients with HGSC and evaluated tumor size,… read more here.
Keywords: grade serous; high grade; serous carcinoma; carcinosarcoma ... See more keywords
Sacituzumab Govitecan (IMMU-132) in treatment-resistant uterine serous carcinoma: A case report
Sign Up to like & getrecommendations! Published in 2018 at "Gynecologic Oncology Reports"
DOI: 10.1016/j.gore.2018.05.009
Abstract: Background Uterine serous carcinoma (USC) is a biologically aggressive variant of uterine cancer. Effective treatment options for recurrent, chemotherapy-resistant USC are extremely limited. Case We describe a 74-year-old woman with recurrent and widespread treatment-resistant disease,… read more here.
Keywords: treatment resistant; uterine serous; treatment; sacituzumab govitecan ... See more keywords
Low-grade Serous Neoplasia of the Female Genital Tract.
Sign Up to like & getrecommendations! Published in 2019 at "Surgical pathology clinics"
DOI: 10.1016/j.path.2019.02.006
Abstract: Low-grade serous neoplasia of the gynecologic tract includes benign (serous cystadenomas), borderline, and malignant lesions (low-grade serous carcinoma). Classification of these lesions relies on rigorous attention to several pathologic features that determine the prognosis and… read more here.
Keywords: grade serous; neoplasia female; tract; serous carcinoma ... See more keywords
The role of neoadjuvant chemotherapy in the management of low-grade serous carcinoma of the ovary and peritoneum: Further evidence of relative chemoresistance.
Sign Up to like & getrecommendations! Published in 2020 at "Gynecologic oncology"
DOI: 10.1016/j.ygyno.2020.06.498
Abstract: OBJECTIVE Low-grade serous carcinoma of the ovary/peritoneum (LGSC) is relatively chemoresistant in the adjuvant, neoadjuvant, and recurrent settings. We sought to expand our prior work and evaluate response rates of women with LGSC to neoadjuvant… read more here.
Keywords: serous carcinoma; carcinoma ovary; hgsc patients; grade serous ... See more keywords
WT1 expression associated with platinum-sensitivity and improved progression-free survival in uterine serous carcinoma
Sign Up to like & getrecommendations! Published in 2021 at "Gynecologic Oncology"
DOI: 10.1016/s0090-8258(21)01290-7
Abstract: Objectives: Wilms tumor gene 1 (WT1) expression is a hallmark of ovarian serous carcinoma (OSC) and considered to be diagnostic marker of these tumors, differentiating them from uterine serous carcinoma (USC), traditionally thought to rarely… read more here.
Keywords: platinum sensitivity; wt1; serous carcinoma; expression ... See more keywords
HER2 in uterine serous carcinoma: Current state and clinical perspectives.
Sign Up to like & getrecommendations! Published in 2023 at "American journal of clinical pathology"
DOI: 10.1093/ajcp/aqad056
Abstract: OBJECTIVES Uterine cancer has the highest incidence and the second-highest mortality rate among gynecologic malignancies in the United States. Although uterine serous carcinoma (USC) represents less than 10% of endometrial carcinomas, it accounts for a… read more here.
Keywords: endometrial cancer; her2; serous carcinoma; uterine serous ... See more keywords
Loss of WT1 Expression After Chemotherapy in a Primary Peritoneal Serous Carcinoma: A Case Report
Sign Up to like & getrecommendations! Published in 2019 at "American Journal of Clinical Pathology"
DOI: 10.1093/ajcp/aqz113.006
Abstract: Primary peritoneal serous carcinoma (PPSC) is defined as a high-grade malignant neoplasm with widespread peritoneal involvement in the setting of normal-sized ovaries that contain small surface tumoral implants and no other identifiable source of malignant… read more here.
Keywords: carcinoma; case; serous carcinoma; peritoneal serous ... See more keywords
Immunosuppressive tumor microenvironment in Uterine Serous Carcinoma via CCL7 signal with myeloid-derived suppressor cells.
Sign Up to like & getrecommendations! Published in 2022 at "Carcinogenesis"
DOI: 10.1093/carcin/bgac032
Abstract: Serous carcinoma of the uterus (USC) is a pathological subtype of high-grade endometrial cancers, with no effective treatment for advanced cases. Since such refractory tumors frequently harbor anti-tumor immune tolerance, many immunotherapies have been investigated… read more here.
Keywords: myeloid derived; suppressor cells; serous carcinoma; derived suppressor ... See more keywords
Low-grade Serous Carcinoma Arising in Inguinal Nodal Endosalpingiosis: Report of 2 Cases and Literature Review.
Sign Up to like & getrecommendations! Published in 2019 at "International Journal of Gynecological Pathology"
DOI: 10.1097/pgp.0000000000000613
Abstract: We report 2 cases of low-grade serous carcinoma probably arising from endosalpingiosis within inguinal lymph nodes. The neoplasms occurred in 51- and 58-yr old women in the absence of tumor within the adnexa, peritoneum or… read more here.
Keywords: serous carcinoma; low grade; report cases; carcinoma arising ... See more keywords
HER2 Testing and Reporting in Endometrial Serous Carcinoma: Practical Recommendations for HER2 Immunohistochemistry and Fluorescent In Situ Hybridization: Proceedings of the ISGyP Companion Society Session at the 2020 USCAP Annual Meeting.
Sign Up to like & getrecommendations! Published in 2021 at "International Journal of Gynecological Pathology"
DOI: 10.1097/pgp.0000000000000711
Abstract: Anti-HER2 therapy has recently emerged as an effective targeted treatment approach for patients with advanced stage and recurrent endometrial serous carcinoma, resulting in significantly prolonged progression-free and overall survival when combined with the standard chemotherapy… read more here.
Keywords: her2 testing; serous carcinoma; pathology; carcinoma ... See more keywords